Philadelphia, PA, United States of America

Irwin S Gibbs

This inventor holds 1 USPTO granted patent. Top assignee: E. R. Squibb Sons, Inc.. Active years: 1980.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Irwin S Gibbs. Retrieved from https://idiyas.com/inventor/irwin-s-gibbs-pake76yi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1980

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Irwin S. Gibbs: Innovator in Pharmaceutical Compositions

Introduction

Irwin S. Gibbs is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of injectable medications. His work has led to advancements that benefit both healthcare providers and patients.

Latest Patents

Irwin S. Gibbs holds a patent for "Cephradine compositions." This patent describes dry solid cephradine compositions that include cephradine and arginine, which can be reconstructed as injectables upon the addition of water. The patent also outlines a method for formulating injectable cephradine, showcasing his innovative approach to pharmaceutical development. He has 1 patent to his name.

Career Highlights

Gibbs is associated with E. R. Squibb Sons, Inc., a company known for its commitment to advancing healthcare through innovative pharmaceutical solutions. His role at the company has allowed him to contribute to the development of important medical formulations.

Collaborations

One of his notable coworkers is Anthony L. La Via. Their collaboration has likely fostered an environment of innovation and creativity within their projects.

Conclusion

Irwin S. Gibbs is a distinguished inventor whose work in cephradine compositions has made a significant impact in the pharmaceutical industry. His contributions continue to influence the development of injectable medications, enhancing patient care and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…